136 related articles for article (PubMed ID: 25926074)
1. miR-888: A Novel Cancer-Testis Antigen that Targets the Progesterone Receptor in Endometrial Cancer.
Hovey AM; Devor EJ; Breheny PJ; Mott SL; Dai D; Thiel KW; Leslie KK
Transl Oncol; 2015 Apr; 8(2):85-96. PubMed ID: 25926074
[TBL] [Abstract][Full Text] [Related]
2. MiR-548c impairs migration and invasion of endometrial and ovarian cancer cells via downregulation of Twist.
Sun X; Cui M; Zhang A; Tong L; Wang K; Li K; Wang X; Sun Z; Zhang H
J Exp Clin Cancer Res; 2016 Jan; 35():10. PubMed ID: 26762267
[TBL] [Abstract][Full Text] [Related]
3. Long Noncoding RNA-ATB Impairs the Function of Tumor Suppressor miR-126-Mediated Signals in Endometrial Cancer for Tumor Growth and Metastasis.
Zheng X; Liu M; Song Y; Feng C
Cancer Biother Radiopharm; 2019 Feb; 34(1):47-55. PubMed ID: 30601064
[TBL] [Abstract][Full Text] [Related]
4. Hsa-microRNA-181a is a regulator of a number of cancer genes and a biomarker for endometrial carcinoma in patients: a bioinformatic and clinical study and the therapeutic implication.
He S; Zeng S; Zhou ZW; He ZX; Zhou SF
Drug Des Devel Ther; 2015; 9():1103-75. PubMed ID: 25733820
[TBL] [Abstract][Full Text] [Related]
5. MiR-449a functions as a tumor suppressor in endometrial cancer by targeting CDC25A.
Ye W; Xue J; Zhang Q; Li F; Zhang W; Chen H; Huang Y; Zheng F
Oncol Rep; 2014 Sep; 32(3):1193-9. PubMed ID: 24993091
[TBL] [Abstract][Full Text] [Related]
6. Reactivation of epigenetically silenced miR-124 reverses the epithelial-to-mesenchymal transition and inhibits invasion in endometrial cancer cells via the direct repression of IQGAP1 expression.
Dong P; Ihira K; Xiong Y; Watari H; Hanley SJ; Yamada T; Hosaka M; Kudo M; Yue J; Sakuragi N
Oncotarget; 2016 Apr; 7(15):20260-70. PubMed ID: 26934121
[TBL] [Abstract][Full Text] [Related]
7. miR-205 inhibits cell growth by targeting AKT-mTOR signaling in progesterone-resistant endometrial cancer Ishikawa cells.
Zhuo Z; Yu H
Oncotarget; 2017 Apr; 8(17):28042-28051. PubMed ID: 28427207
[TBL] [Abstract][Full Text] [Related]
8. Highly increased maspin expression corresponds with up-regulation of miR-21 in endometrial cancer: a preliminary report.
Torres A; Torres K; Paszkowski T; Radej S; Staśkiewicz GJ; Ceccaroni M; Pesci A; Maciejewski R
Int J Gynecol Cancer; 2011 Jan; 21(1):8-14. PubMed ID: 21330826
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-505 functions as a tumor suppressor in endometrial cancer by targeting TGF-α.
Chen S; Sun KX; Liu BL; Zong ZH; Zhao Y
Mol Cancer; 2016 Feb; 15():11. PubMed ID: 26832151
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-874 Functions as a Tumor Suppressor by Targeting Cancer/Testis Antigen HCA587/MAGE-C2.
Song X; Song W; Wang Y; Wang J; Li Y; Qian X; Pang X; Zhang Y; Yin Y
J Cancer; 2016; 7(6):656-63. PubMed ID: 27076846
[TBL] [Abstract][Full Text] [Related]
11. microRNA regulation of the expression of the estrogen receptor in endometrial cancer.
Zhou J; Song T; Gong S; Zhong M; Su G
Mol Med Rep; 2010; 3(3):387-92. PubMed ID: 21472251
[TBL] [Abstract][Full Text] [Related]
12. [Differential expression of microRNAs associated with estrogen receptor alpha and progesterone receptor in typeIand typeII endometrial adenocarcinomas.].
Zhou J; Shen K; Zeng JF; Yang JX; Cao DY; Cui QC
Zhonghua Fu Chan Ke Za Zhi; 2009 Oct; 44(10):765-70. PubMed ID: 20078964
[TBL] [Abstract][Full Text] [Related]
13. Clinical value screening, prognostic significance and key pathway identification of miR-204-5p in endometrial carcinoma: A study based on the Cancer Genome Atlas (TCGA), and bioinformatics analysis.
Guo S; Yang J; Wu M; Xiao G
Pathol Res Pract; 2019 May; 215(5):1003-1011. PubMed ID: 30910254
[TBL] [Abstract][Full Text] [Related]
14. LINC01016 promotes the malignant phenotype of endometrial cancer cells by regulating the miR-302a-3p/miR-3130-3p/NFYA/SATB1 axis.
Pan X; Li D; Huo J; Kong F; Yang H; Ma X
Cell Death Dis; 2018 Feb; 9(3):303. PubMed ID: 29467441
[TBL] [Abstract][Full Text] [Related]
15. miR-142-3p as tumor suppressor miRNA in the regulation of tumorigenicity, invasion and migration of human breast cancer by targeting Bach-1 expression.
Mansoori B; Mohammadi A; Ghasabi M; Shirjang S; Dehghan R; Montazeri V; Holmskov U; Kazemi T; Duijf P; Gjerstorff M; Baradaran B
J Cell Physiol; 2019 Jun; 234(6):9816-9825. PubMed ID: 30480817
[TBL] [Abstract][Full Text] [Related]
16. Investigations on the mechanism of progesterone in inhibiting endometrial cancer cell cycle and viability via regulation of long noncoding RNA NEAT1/microRNA-146b-5p mediated Wnt/β-catenin signaling.
Huang X; Zhong R; He X; Deng Q; Peng X; Li J; Luo X
IUBMB Life; 2019 Feb; 71(2):223-234. PubMed ID: 30452118
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA regulation of progesterone receptor in breast cancer.
Gilam A; Shai A; Ashkenazi I; Sarid LA; Drobot A; Bickel A; Shomron N
Oncotarget; 2017 Apr; 8(16):25963-25976. PubMed ID: 28404930
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-34b functions as a potential tumor suppressor in endometrial serous adenocarcinoma.
Hiroki E; Suzuki F; Akahira J; Nagase S; Ito K; Sugawara J; Miki Y; Suzuki T; Sasano H; Yaegashi N
Int J Cancer; 2012 Aug; 131(4):E395-404. PubMed ID: 22052540
[TBL] [Abstract][Full Text] [Related]
19. A novel cancer testis antigen that is frequently expressed in pancreatic, lung, and endometrial cancers.
Okada T; Akada M; Fujita T; Iwata T; Goto Y; Kido K; Okada T; Matsuzaki Y; Kobayashi K; Matsuno S; Sunamura M; Kawakami Y
Clin Cancer Res; 2006 Jan; 12(1):191-7. PubMed ID: 16397042
[TBL] [Abstract][Full Text] [Related]
20. miR-200a, miR-200b and miR-429 are onco-miRs that target the PTEN gene in endometrioid endometrial carcinoma.
Yoneyama K; Ishibashi O; Kawase R; Kurose K; Takeshita T
Anticancer Res; 2015 Mar; 35(3):1401-10. PubMed ID: 25750291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
